Maternal inflammation risk factors linked to dysregulation in children

In February, we reported on the emerging problem of xylazine-laced fentanyl. In this report, we follow up on what has happened since doctors first started

Ar­row­head Phar­ma­ceu­ti­cals has un­veiled high­ly an­tic­i­pat­ed pan­cre­ati­tis re­sults from a late-phase tri­al of ploza­sir­an for a rare lipid dis­or­der, sev­er­al months af­ter re­port­ing topline da­ta